Frontlight ResearchEarly access
Trial site
Institutul Privat de Cercetări Melchisedec pentru Boli Autoimune, Ereditare și Rare -I.P.C.M
- 2running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Depression2 trials
- Bipolar disorder1 trial
- Schizophrenia1 trial
- Phase
- Phase 33 trials
- Early phase 11 trial
- Status
- Recruiting2 trials
- Suspended2 trials
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
- Massachusetts General Hospital1 trial
- Xenon Pharmaceuticals Inc.1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Schizophrenia1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026